Free Trial

Procter & Gamble (NYSE:PG) Stock: Insider Sundar Raman Sells 38,253 Shares

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • CEO Sundar Raman sold 38,253 Procter & Gamble shares at $165 each, totaling $6.31 million and reducing his direct ownership by 44.48%.
  • Procter & Gamble reported quarterly EPS of $2.00, beating estimates of $1.89, while revenue rose 4% year over year to $23.28 billion.
  • The company declared a quarterly dividend of $1.0885 per share, equivalent to an annualized $4.35 dividend and a 2.7% yield; analysts maintain a “Moderate Buy” consensus with an average price target of $170.57.
  • Interested in Procter & Gamble? Here are five stocks we like better.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) CEO Sundar Raman sold 38,253 shares of Procter & Gamble stock in a transaction dated Friday, October 30th. The stock was sold at an average price of $165.00, for a total value of $6,311,745.00. Following the transaction, the chief executive officer directly owned 47,745 shares in the company, valued at approximately $7,877,925. The trade was a 44.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Procter & Gamble Trading Down 1.0%

Procter & Gamble stock traded down $1.59 during midday trading on Tuesday, reaching $161.97. The stock had a trading volume of 1,555,851 shares, compared to its average volume of 9,691,114. The firm's fifty day simple moving average is $150.37 and its two-hundred day simple moving average is $149.04. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The firm has a market cap of $375.40 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 3.89 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the prior year, the business posted $1.99 EPS. Procter & Gamble's quarterly revenue was up 4.0% on a year-over-year basis. Equities analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 65.51%.

Institutional Investors Weigh In On Procter & Gamble

Several institutional investors have recently bought and sold shares of PG. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at $26,000. Montgomery Financial Services LLC bought a new position in Procter & Gamble during the second quarter worth about $28,000. Paladin Partners LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at approximately $29,000. Evergreen Advisors LLC bought a new position in Procter & Gamble in the 1st quarter worth approximately $37,000. Finally, Toews Corp ADV bought a new stake in Procter & Gamble during the 2nd quarter valued at $37,000. Institutional investors own 65.77% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PG. Weiss Ratings reiterated a "hold (c)" rating on shares of Procter & Gamble in a research note on Monday, September 21st. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Procter & Gamble in a research report on Friday, October 23rd. Bank of America dropped their price objective on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a report on Friday, July 10th. Piper Sandler increased their price target on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a "neutral" rating in a research report on Monday, October 26th. Finally, Wells Fargo & Company increased their target price on shares of Procter & Gamble from $164.00 to $180.00 and gave the stock an "overweight" rating in a report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and an average target price of $170.57.

Get Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Featured Articles

Insider Buying and Selling by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines